PM070 Alirocumab In Patients With Hypertension and Hypercholesterolemia: Pooled Analysis From the Odyssey Phase 3 Trials

Abstract

Peer reviewed

R. Santos, K.C. Ferdinand, R.S. Wright, E.P. Navarese, M.J. Louie, L.V. Lee, G. Asset and J.G. Robinson

Global heart, Vol.11(2), pp.e81-e82

06/2016

DOI: 10.1016/j.gheart.2016.03.283

View Online

Title: Subtitle: PM070 Alirocumab In Patients With Hypertension and Hypercholesterolemia: Pooled Analysis From the Odyssey Phase 3 Trials
Creators: R. Santos - Universidade de São Paulo
K.C. Ferdinand - Tulane University
R.S. Wright - Division of Cardiovascular Diseases, Mayo Clinic Rochester, United States
E.P. Navarese - Heinrich Heine University Düsseldorf
M.J. Louie - Regeneron
L.V. Lee - Sanofi, Bridgewater, United States
G. Asset - Sanofi
J.G. Robinson - University of Iowa
Resource Type: Abstract
Publication Details: Global heart, Vol.11(2), pp.e81-e82
Publisher: Elsevier B.V
DOI: 10.1016/j.gheart.2016.03.283
ISSN: 2211-8160
eISSN: 2211-8179
Language: English
Date published: 06/2016
Academic Unit: Epidemiology; Fraternal Order of Eagles Diabetes Research Center
Record Identifier: 9984364539802771

6 Record Views